Healthcare benefits of very-low-dose combination treatment used in the management of hypertension

Journal of Hypertension, Supplement

Volumn 19, Issue 4, 2001, Pages

  Ambrosioni, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hypertension; Management; Pharmacoeconomics; Very low dose combination treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COMBINATION; DRUG TOLERANCE; ECONOMICS; HUMAN; HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTIHYPERTENSIVE AGENTS; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS;

EID: 0035522730     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Hilleman DE, Mohiuddin SM, Lucas BD, Stading JA, Stoysich AM, Ryschon K, et al. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Clin Ther 1994; 16:88-102.
2. Ambrosioni E, Costa FV. Cost-effectiveness calculations from trials. J Hypertens 1996; 14 (suppl. 2):S47-S54.
3. Kannel WB. Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 1996; 275:1571-1576.
4. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.